Clinical Trial

Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma.

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 4, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to learn about the different treatment options for intermediate-stage hepatocellular carcinoma. The main question it aims to answer is: \- What are the survival outcomes among participants aged 18 or older who receive treatment for intermediate-stage hepatocellular carcinoma?
Trial Details
NCT Number NCT07449637
Lead Sponsor Sohag University
Collaborators: Sohag Oncology Center
Conditions BCLC Stage B Hepatocellular Carcinoma
Enrollment 200 participants
Start Date 2026-03
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-04